Trade

Vaishali Pharma share price

  • NaN%Low risk
  • NaN%Moderate risk
  • NaN%Balanced risk
  • NaN%High risk
  • NaN%Extreme risk
  • 7.00(0.72%)
    May 15, 2026 15:29:46 PM IST
    • NSE
    • BSE
  • Vol : 111.94 K (NSE + BSE)
    Last 20 day avg : 404.14 K

Vaishali Pharma is trading 0.72% upper at Rs 7.00 as compared to its last closing price. Vaishali Pharma has been trading in the price range of 7.20 & 6.96. Vaishali Pharma has given -19.37% in this year & -6.84% in the last 5 days. Vaishali Pharma has TTM P/E ratio 27.35 as compared to the sector P/E of 24.31.The company posted a net profit of 1.32 Crores in its last quarter.Listed peers of Vaishali Pharma include Sun Pharmaceutical Industries (0.90%), Cipla (-0.49%), Torrent Pharmaceuticals (-0.52%).The Mutual Fund holding in Vaishali Pharma was at -% in . The MF holding has - from the last quarter. The FII holding in Vaishali Pharma was at 0.02% in 17 May 2024. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on May 17, 2026, 08:56 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.94
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.19
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -0.49
    Indicates undervaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
6.96
Highest
7.20
52 week range
Lowest
4.75
Highest
13.59
Vaishali Pharma Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bullish
1,879.900.904,51,076.6736.245.770.920.50
Cipla
Moderately Bullish
1,431.55-0.491,16,013.1022.953.870.870.81
Torrent Pharmaceuticals
Bullish
4,386.00-0.521,48,148.9267.3217.10.8317.62
Dr Reddy's Laboratories
Bullish
1,336.952.621,11,584.2418.633.140.632.34
Divi's Laboratories
Bullish
6,755.00-2.411,78,679.9978.6111.520.460.01
Vaishali Pharma Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-13Quarterly Results & Others
2025-11-14Quarterly Results
2025-08-11Quarterly Results & Others
2025-05-28Audited Results & Others
2025-02-06Quarterly Results & Others
About the company Vaishali Pharma
  • IndustryBiotechnology & Drugs
  • ISININE972X01022
  • BSE Code
  • NSE CodeVAISHALI
Vaishali Pharma Limited is an India-based pharmaceutical company. The Company is in the pharmaceutical business, mainly dealing in active pharmaceutical ingredients, pharmaceutical formulations, surgical products, and veterinary supplements, operating in domestic and export markets. Its product categories include active pharmaceutical ingredients (APIs), formulation brands, formulations, herbal, nutraceutical, oncology, surgical, and veterinary. The Company has manufactured and exported approximately 250 formulations and specializes in manufacturing tailor-made formulations. It offers APIs, including antibiotics, anti-ulcer, anti-inflammatory/analgesic/ anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, antiviral, antifungal, skeletal muscle relaxant, and anthelmintic drugs, excipients, topical steroids, corticosteroids, and enzymes. It has a global presence in Asia & Pacific, Africa, the Commonwealth of Independent States, America, and the Middle East.
  • Management Info
  • Atul VasaniChairman of the Board, Managing Director
  • Hemanth PathakChief Executive Officer
  • Dewansh VasaniChief Financial Officer, Executive Director
  • Akshay JharkhandiCompany Secretary & Compliance Officer
  • Jagruti VasaniWhole Time Director
Vaishali Pharma Share Price FAQs

Vaishali Pharma is trading at 7.00 as on Fri May 15 2026 09:59:46. This is 0.72% upper as compared to its previous closing price of 6.95.

The market capitalization of Vaishali Pharma is 91.32 Cr as on Fri May 15 2026 09:59:46.

The 52 wk high for Vaishali Pharma is 13.59 whereas the 52 wk low is 4.75

Vaishali Pharma can be analyzed on the following key metrics -

  • TTM P/E: 27.35
  • Sector P/E: 24.31
  • Dividend Yield: 0.00%
  • D/E ratio: -

Vaishali Pharma reported a net profit of 0.82 Cr in 2025.